Measles cases have increased globally, with an estimated 11 million infections in 2024—about 800,000 more than pre-pandemic levels in 2019.
This new facility aims to help Liberia achieve WHO Maturity Level 3, a benchmark the country has sought for decades without success.
Mjn-neuro’s wearable sensor uses artificial intelligence (AI) to analyze electrical brain signals and predict when a seizure will occur.
Itvisma works by delivering a functional copy of the survival motor neuron 1 (SMN1) gene through a single, fixed-dose intrathecal injection.
WT-7695, a preclinical radiopharmaceutical targeting carbonic anhydrase IX (CA9), was developed in collaboration with the University of Wisconsin-Madison, and SK now holds exclusive worldwide rights to develop, manufacture, and market the drug.
This system will ensure that Egyptians can access high-quality healthcare services securely and equitably through nationally unified health data platforms.
Claritag® utilizes a patented Squeeze & Freeze® technology, providing a fast and effective way for adults aged 21 and older to remove skin tags safely at home.
The DMEK technique – Descemet’s membrane endothelial keratoplasty – is the most advanced method used internationally to treat endothelial diseases such as Fuchs’ dystrophy and corneal edema after cataract surgery.
This renewal reinforces the hospital’s status as a leading destination in the region for aesthetic and elective procedures.
This progress was announced by Dr. Temitope Ilori, the Director-General of the National Agency for the Control of AIDS (NACA), during the World AIDS Day 2025 observance in Abuja.